Neoadjuvant therapy for hepatocellular carcinoma: Is there an optimal approach?

ONCOLOGY

Volumn 21, Issue 9, 2007, Pages 1116-1122

  Almhanna, Khaldoun ^a   Kalmadi, Sujith ^a   Pelley, Robert ^a   Kim, Richard ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DOXORUBICIN; FLUOROURACIL; LEVAMISOLE; SORAFENIB;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER SURGERY; CHEMOEMBOLIZATION; COMBINATION CHEMOTHERAPY; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; ORGAN DONOR; OUTCOME ASSESSMENT; RADIOFREQUENCY ABLATION; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH; UNITED STATES;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; ETHANOL; HUMANS; NEOADJUVANT THERAPY; PYRIDINES;

EID: 34548307023     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Munoz N, Bosch X: Epidemiology of hepatocellular carcinoma, in Okuda K, Ishak KG (eds): Neoplasms of the Liver. Tokyo, Springer, 1989.
2. Davila JA, Morgan RO, Shaib Y, et al: Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study Gastroenterology 127:1372-1380, 2004.
3. El-Serag HB: Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology. 127(5 suppl 1):S27-S34, 2004.
4. Sheu JC, Sung JL, Chen DS, et al: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89:259-266, 1985.
5. Barnett CC Jr, Curley SA; Ablative techniques for hepatocellular carcinoma. Semin Oncol 28:487-496, 2001.
6. Tateishi R, Shiina S, Teratani T, et al: Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 103:1201-1209, 2005.
7. Johnson EW, Hoick PS, Levy AE, et al: The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 139:825-830 (incl discussion), 2004.
8. Lu DS, Yu NC, Raman SS, et al: Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41:1130-1137, 2005.
9. Fontana RJ, Hamidullah H, Nghiem H, et al: Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation. Liver Transpl 8:1165-1174, 2002.
10. Mazzaferro V, Battiston C, Perrone S, et al: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 240:900-909, 2004.
11. Shiina S, Tagawa K, Unuma T, et al: Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 68:1524-1530, 1991.
12. Livraghi T, Giorgio A, Marin G: Hepatocellular carcinoma and cirrhosis in 746 patients; Long-term results of percutaneous ethanol injection. Radiology 197:101-108, 1995.
13. Castells A, Bruix J, Bru C, et al: Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18:1121-1126, 1993.
14. Castroagudin JF, Delgado M, Villanueva A, et al: Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates. Transplant Proc 37:3871-3873, 2005.
15. Pompili M, Mirante VG, Rondinara G, et al: Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 11:1117-1126, 2005.
16. Vauthey JN, Klimstra D, Franceschi D, et al: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28-34, 1995.
17. Poon RT, Fan ST, Lo CM, et al: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg 235:373-382, 2002.
18. Belghiti J, Cortes A, Abdalla EK, et al: Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238:885-893 (incl discussion), 2003.
19. Majno PE, Sarasin FP, Mentha G, et al: Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis. Hepatology 31:899-906, 2000.
20. Adam R, Azoulay D, Castaing D, et al: Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg 238:508-519 (incl discussion), 2003.
21. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection vs transplantation. Hepatology 30:1434-1440, 1999.
22. Llovet JM, Schwartz M, Mazzaferro V: Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25:181-200, 2005.
23. Maddala YK, Stadheim L, Andrews JC, et al: Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transpl 10:449-455, 2004.
24. Graziadei IW, Sandmueller H, Waldenberger P, et al: Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9:557-563, 2003.
25. Harnois DM, Steers J, Andrews JC, et al: Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5:192-199, 1999.
26. Troisi R, Defreyne L, Hesse UJ, et al: Multimodal treatment for hepatocellular carcinoma on cirrhosis: The role of chemoembolization and alcoholization before liver transplantation. Clin Transplant 12:313-319, 1998.
27. Oldhafer KJ, Chavan A, Fruhauf NR, et al: Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit? J Hepatol 29:953-959, 1998.
28. Lesurtel M, Mullhaupt B, Pestalozzi BC, et al: Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: An evidence-based analysis. Am J Transplant 6:2644-2650, 2006.
29. Spreafico C, Marchiano A, Regalia E, et al: Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 192:687-690, 1994.
30. Hayashi PH, Ludkowski M, Forman LM, et al: Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 4:782-787, 2004.
31. Soini Y, Virkajarvi N, Raunio H, et al: Expression of P-glycoprotein in hepatocellular carcinoma: A potential marker of prognosis. J Clin Pathol 49:470-473, 1996.
32. Olweny CL, Toya T, Katongole-Mbidde E, et al: Treatment of hepatocellular carcinoma with Adriamycin. Preliminary communication. Cancer 36:1250-1257, 1975.
33. Lai CL, Wu PC, Chan GC, et al: Doxorubicin vs no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 62:479-483, 1988.
34. Stone MJ, Klintmalm GB, Polter D, et al: Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients. Gastroenterology 104:196-202, 1993.
35. Olthoff KM, Rosove MH, Shackleton CR, et al: Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 221: 734-743, 1995.
36. Carr BI, Selby R, Madariaga J, et al: Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Trans Proc 25: 1128-1129, 1993.
37. Abou-Alfa GK, Schwartz L, Ricci S, et al: Phase II study of Sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 10; 24:4293-300, 2006.
38. Maluf D, Fisher RA, Maroney T, et al: Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): Safety and efficacy. Am J Transplant 3:312-317, 2003.
39. Veltri A, Grosso M, Martina MC, et al: Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study. Cardiovasc Intervent Radio 21:393-398, 1998.
40. Fisher RA, Maluf D, Cotterell AH, et al: Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 18:502-512, 2004.
41. Roayaie S, Frischer JS, Emre SH, et al: Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533-539, 2002.
42. Bharat A, Brown DB, Crippin JS, et al: Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve long-term survival. J Am Coll Surg 203:411-420, 2006.